Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bizhar Ahmed Tayeb has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Therapeutic intervention strategies for Nipah virus infection: a scoping review

    by Ikhwan Yuda Kusuma, Bizhar Ahmed Tayeb, Muhammad Jayyid Zidan, Septi Nurkhasanah, Rian Nurahman, Ilil Maidatuz Zulfa

    Nipah virus (NiV) infection, a zoonotic disease, has caused recurrent outbreaks in South and Southeast Asia, with case fatality rates ranging from 38% to 75%. The clinical management of NiV disease (NiVD) relies on supportive care, with unapproved antiviral therapies and no licensed vaccines currently available. This scoping review aims to synthesise and map the available evidence on therapeutic strategies for NiV infection. A systematic search was conducted in PubMed and Scopus for studies published from 1 January 1999 to 1 February 2026, focusing on clinical studies, animal experiments, in vitro investigations and in silico analyses evaluating NiV therapies. Eligible studies were selected based on their population or experimental model, therapeutic intervention, evaluation methods, efficacy outcomes, safety findings and proposed molecular mechanisms. Of 1703 articles screened, 16 studies were included, covering clinical reports, animal models, in vitro experiments and in silico analyses. Therapeutic interventions evaluated included antivirals (ribavirin, favipiravir, remdesivir and RdRp-targeted candidates), passive immunotherapy (monoclonal antibodies targeting viral glycoproteins) and computationally prioritised compounds (e.g. phytochemicals, bioisosteres and repurposed drugs). Most interventions targeted viral entry, RNA replication or multiple stages of the NiV life cycle. However, a substantial gap exists between the urgent clinical need for effective treatments and the limited availability of clinically validated therapies. Effective, clinically validated therapies for NiV infection are still lacking. Translational research, outbreak-ready clinical trial frameworks and prioritisation of promising therapeutic candidates are crucial for improving preparedness and clinical outcomes in future NiV outbreaks.


  • Open Access

    Liquid biopsy biomarkers in cervical cancer: A systematic review and meta-analysis

    by Isaac Kinyua Njangiru, Bizhar Ahmed Tayeb, Hazhmat Ali, Rafl M. Kamil


  • Open Access

    Exploring Dietary Patterns and Breast Cancer Risk: Epidemiological Insight from Sulaymaniyah City, Iraq

    by Hanar Azad Abdulrahman, Gasha Abdalla Mohammed, Dina Tariq Abdalghafoor, Rafl Malek Kamil, Raneen Subhi Atiyah, Najmaddin S.H. Khoshnaw, Bizhar Ahmed Tayeb, Lanja Ibraheim Saeed, Harnd Abdalla Ali, Paiwand Faraidun Sabir

    Objective: An increasing number of women are being diagnosed with breast cancer, which ranks as one of the most common cancers in women globally, particularly in developed nations. Although genetic environmental factors and lifestyle choices are all contributors to breast cancer risk, dietary habits are known to play a modifiable role in both the disease›s prevalence and prognosis; therefore, the aim of this study was to correlate dietary habits with the prevalence of breast cancer in Sulaymaniyah city, Iraq.Methods: Hiwa Oncological Hospital in Iraq›s Sulaymaniyah City was the site of the research. In all, 301 individuals who received a breast cancer diagnosis between June 2023 and January 2024 were included in the sample size. Patient demographics, medical history, eating habits, and other crucial details related to daily dietary regimens were among the data obtained. Once collected, the data were processed via IBM SPSS Statistics.Results: Among 301 breast cancer patients, 43.5% were aged 40--49 years, and 85.6% were married. Invasive ductal carcinoma (IDC) is the most prevalent subtype. Most patients (82.7%) followed a balanced diet, with IDC being the predominant subtype (73.9%). The majority (63.5%) consumed fruits and vegetables 1–2 times daily, while only 1% exceeded five servings. Additionally, 58.1% had no dietary restrictions, whereas 29.6% avoided sugar, meat, or fatty foods. It was observed that patients with uncontrolled dietary habits and lower fruit and vegetable intake were more likely to develop invasive breast cancer subtypes.Conclusion: These results emphasize the necessity of advocating for healthier lifestyles through nutritional habits and screening in order to decrease the increasing breast cancer burden in the region. In order to lower the incidence of breast cancer and improve outcomes, it may be essential to implement dietary interventions and early screening techniques within the population.

  • Open Access

    Synthesis and Antiproliferative Effect of New Alkyne-Tethered Vindoline Hybrids Containing Pharmacophoric Fragments

    by Etelka Ferenczi, Péter Keglevich, Bizhar Ahmed Tayeb, Renáta Minorics, Dávid Papp, Gitta Schlosser, István Zupkó, László Hazai, Antal Csámpai

    In the frame of our diversity-oriented research on multitarget small molecule anticancer agents, utilizing convergent synthetic sequences terminated by Sonogashira coupling reactions, a preliminary selection of representative alkyne-tethered vindoline hybrids was synthesized. The novel hybrids with additional pharmacophoric fragments of well-documented anticancer agents, including FDA-approved tyrosine-kinase inhibitors (imatinib and erlotinib) or ferrocene or chalcone units, were evaluated for their antiproliferative activity on malignant cell lines MDA-MB-231 (triple negative breast cancer), A2780 (ovarian cancer), HeLa (human cervical cancer), and SH-SY5Y (neuroblastoma) as well as on human embryonal lung fibroblast cell line MRC-5, which served as a reference non-malignant cell line for the assessment of the therapeutic window of the tested hybrids. The biological assays identified a trimethoxyphenyl-containing chalcone-vindoline hybrid (36) as a promising lead compound exhibiting submicromolar activity on A2780 cells with a marked therapeutic window.


  • Open Access

    Synthesis and Antiproliferative Effect of New Alkyne-Tethered Vindoline Hybrids Containing Pharmacophoric Fragments

    by Etelka Ferenczi, Péter Keglevich, Bizhar Ahmed Tayeb, Renáta Minorics, Dávid Papp, Gitta Schlosser, István Zupkó, László Hazai, Antal Csámpai

    In the frame of our diversity-oriented research on multitarget small molecule anticancer agents, utilizing convergent synthetic sequences terminated by Sonogashira coupling reactions, a preliminary selection of representative alkyne-tethered vindoline hybrids was synthesized. The novel hybrids with additional pharmacophoric fragments of well-documented anticancer agents, including FDA-approved tyrosine-kinase inhibitors (imatinib and erlotinib) or ferrocene or chalcone units, were evaluated for their antiproliferative activity on malignant cell lines MDA-MB-231 (triple negative breast cancer), A2780 (ovarian cancer), HeLa (human cervical cancer) and SH-SY5Y (neuroblastoma) as well as human embryonal lung fibroblast MRC-5 served as reference non-malignant cell line for the assessment of the therapeutic window of the tested hybrids. The biological assays identified a trimethoxyphenyl-containing chalcone-vindoline hybrid (36) as a promising lead compound exhibiting submicromolar activity on A2780 cells with a marked therapeutic window. These results suggest that ovarian cancer might be considered as a prioritized target of treatment with 36.


  • Open Access

    Beyond boundaries: Neuroprotective effects of steroids and ecdysteroids in SH‐SY5Y cells ‐ A systematic review

    by Bizhar Ahmed Tayeb, Isaac Kinyua Njangiru, Renáta Minorics

    Steroids and ecdysteroids have been shown to exhibit a range of biological effects, including anti‐inflammatory, anticancer, and neuroprotective. This systematic review aims to highlight the evidence‐based neuroprotective and antioxidant effects of steroids and ecdysteroids in SH‐SY5Y neuroblastoma cells. A comprehensive literature search was conducted on May 11, 2023, without publication source restrictions, using various electronic databases, including PubMed, Web of Science (WoS), Scopus, and Cumulative Index to Nursing and Allied Health Literature. Of 103 articles, only 20 studies were included for investigating the neuroprotective effects of steroids and ecdysteroids in SH‐SY5Y cells exposed to oxidative stress or neurotoxic agents. The risk of bias and quality assessment of the included studies were evaluated in accordance with the Nature Publication Quality Improvement Project specific criteria. The selected studies reported the antioxidant effects of the tested compounds on SH‐SY5Y cells and demonstrated their ability to scavenge free radicals and prevent lipid peroxidation. These findings suggest that neurosteroids have potential therapeutic applications for the prevention and treatment of neurodegenerative diseases characterized by oxidative stress and neuronal damage. Some studies have investigated the molecular mechanisms underlying the neuroprotective and antioxidant effects of steroids and ecdysteroids in SH‐SY5Y cells. These mechanisms include the activation of antioxidant enzymes, such as superoxide dismutase and glutathione peroxidase, and the modulation of various signaling pathways, including the phosphoinositide 3‐kinase/protein kinase B and mitogen‐activated protein kinase/extracellular signal‐regulated kinase pathways. This review provides evidence that the tested compounds have remarkable neuroprotective and antioxidant effects in human neuroblastoma SH‐SY5Y cells.


  • Open Access

    Thymoquinone-Protoflavone Hybrid Molecules as Potential Antitumor Agents

    by Sara H. H. Ahmed, Bizhar A. Tayeb, Tímea Gonda, Gábor Girst, Kornél Szőri, Róbert Berkecz, István Zupkó, Renáta Minorics, Attila Hunyadi

    We describe herein the synthesis of eight new ester-coupled hybrid compounds from thymoquinone and protoflavone building blocks, and their bioactivity testing against multiple cancer cell lines. Among the hybrids, compound 14 showed promising activities in all cell lines studied. The highest activities were recorded against breast cancer cell lines with higher selectivity to MDA-MB-231 as compared to MCF-7. Even though the hybrids were found to be completely hydrolysed in 24 h under cell culture conditions, compound 14 demonstrated a ca. three times stronger activity against U-87 glioblastoma cells than a 1:1 mixture of its fragments. Protoflavone-thymoquinone hybrids may therefore serve as potential new antitumor leads particularly against glioblastoma.